<DOC>
	<DOC>NCT02954094</DOC>
	<brief_summary>TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.</brief_summary>
	<brief_title>A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1. Male or female patients, age â‰¥18 years 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and nonsurgical treatment, as well as those being followed without specific HCC therapy may be included) 1. Inability to provide written informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>